Frontlight ResearchEarly access
Trial site
Cardinal Glennon Children's Hospital
- 4running trials
- 3closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers4 trials
- Neuroblastoma2 trials
- Congenital heart disease1 trial
- Sickle cell disease1 trial
- Phase
- Phase 23 trials
- Phase 32 trials
- Status
- Recruiting3 trials
- Completed2 trials
- Active, not recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Giselle Sholler3 trials
- Asklepion Pharmaceuticals, LLC1 trial
- Indiana University1 trial
- Medical College of Wisconsin1 trial
- Takeda1 trial
Running trials
Recruiting
Recruiting
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Recruiting
Active, not recruiting
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers2 recruiting
- Neuroblastoma1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026